Staging and prognosis. Prior to becoming invasive, there are two different types of precursor lesions: non-invasive papillary urothelial carcinoma and in-situ urothelial carcinoma. Carcinoma in situ involving the bladder diffusely without an associated superficial tumor is also considered an aggressive disease. Urol Oncol. The effect of concomitant carcinoma in situ on neoadjuvant chemotherapy for urothelial cell carcinoma of the bladder: inferior pathological outcomes but no effect on survival. UC with divergent differentiation is the most common variant of UC. As the disease progresses, it may spread. The morphologic definition of carcinoma in situ is arbitrary and generally defined as a total replacement of the urothelial surface by cells which bear morphologic features of carcinoma, but which lack architectural alteration other than an increase in the number of cell layers, i.e., a flat lesion. When the tumour cells are only seen in the epithelium, the disease is called urothelial carcinoma in situ. Summary This chapter contains sections titled: Definition, Terminology, and Historical Perspective Clinical Features Special Considerations Histopathology and Diagnostic Criteria Variants of … Papillary urothelial carcinoma is a type of bladder cancer. Muscle invasive urothelial carcinoma has been treated with cystectomy ± adjuvant therapy. 2 1 Department of Pathology and Laboratory Medi-cine, Roswell Park Cancer Institute, Buffalo, New York. 2 Department of Research, Basel University Hospi-tal and Medical School, Basel, Switzerland. Most patients with this type of cancer will develop invasive cancers of the bladder. Types of Urothelial Cancer. 2017 Apr;35(4):151.e17-151.e23. Plasmacytoid urothelial carcinoma (PUC) is a unique variant of invasive urothelial carcinoma characterized by tumor cells that exhibit a striking resemblance to plasma cells, and it is known to have an aggressive behavior. Parker WP(1), Ho PL(2), Melquist JJ(2), Scott K(1), Holzbeierlein JM(1), Lopez-Corona E(3), Kamat AM(2), Lee EK(4). 1. An Analysis of Cytokeratin 20, P53, and CD44 Antigens. The 2016 World Health Organization (WHO) classification lists subtypes for squamous, glandular, and trophoblastic differentiation. The inferior vena cava tumour thrombus, which is a hallmark of renal cell carcinoma (RCC), may rarely be found in urothelial carcinoma of renal pelvis. Papillary urothelial carcinoma is a form of bladder cancer. Urothelial carcinoma sited at the urinary bladder, renal pelvis and/ or ureter can be classified into localized, regional and metastatic. 1 Juerg Schwaller, M.D. The presence of carcinoma in situ at radical cystectomy increases the risk of urothelial recurrence: Implications for follow-up schemes. The diagnosis of urothelial carcinoma is usually made after a pathologist looks at a urine sample or biopsy taken from the bladder through a microscope. carcinoma in situ Increased p16 expression was also seen in most invasive urothelial carcinoma but did not correlate with grade or stage The Christie NHS Foundation Trust Cytokeratin 5/6 distinguishes reactive urothelial atypia from carcinoma in situ and non-invasive urothelial carcinoma Belanger EC et al. Papillary urothelial lesions span a range from hyperplasia to high grade carcinoma ... Department of Pathology Stanford University School of Medicine Stanford CA 94305-5342 . This program was designed to help Urology residents and fellows familiarize themselves with the pathologic features of common urologic entities. This will serve not only as a resource tool for your review but also as a quick reference guide to urologic pathology. Classification along this continuous spectrum of atypia can be one of the most challenging areas in all genitourinary pathology. glandular urothelial carcinoma It starts in urothelial cells in the bladder lining. It can spread to the areas around your bladder or to other parts of your body (metastasis). Urothelial cells also line the urethra, ureters, and other parts of the urinary tract. †×40. non-invasive urothelial carcinoma. Morphologic expressions of urothelial carcinoma in situ: a detailed evaluation of its histologic patterns with emphasis on carcinoma in situ with microinvasion. Recently, a bladder-sparing protocol has been offered to selected patients closely followed with surveillance biopsies. Epub 2016 Dec 5. The most common type of bladder cancer is called urothelial carcinoma. American Journal of Surgical Pathology 25 (8): 1074-1078, 2001. The mean age at diagnosis was 63.7 years (range: 44-77 years), and the male to female ratio was 1.1:1 ().With the exception of 1 case, which was located in the renal pelvis, the remaining cases were from the bladder. Seventy-nine percent of in situ adenocarcinomas showed >5 mitoses/10 HPF and 42% showed >10 mitoses/10 HPF. The metastatic stage can only be determined if tissue from a distant site is submitted for pathological examination. *×20. Describe the typical clinical presentation of urothelial carcinoma and the advantages and limitations of urine cytology in diagnosis and surveillance of urothelial carcinoma. Sarcomatoid variant of urothelial carcinoma (SVUC) of the renal pelvis is a rare entity. Schematic of the major pathways for the progression of urothelial carcinoma demonstrating the distinct pathogenesis of high-grade and low-grade urothelial lesions. Urothelial cells with dark (jet black) chromatin. non-invasive papillary urothelial carcinoma; non-invasive flat urothelial carcinoma / urothelial carcinoma in situ invasive urothelial carcinoma. 4 It is recommended that the percentage of differentiated tissue be included in the pathology report. Separate EAU guidelines documents are available addressing non-muscle-invasive bladder cancer [1], muscle-invasive and metastatic bladder cancer (MIBC) [2], and primary urethral carcinoma [3]. PATHOLOGY 3.1 Epidemiology Urothelial carcinomas (UCs) are the fourth most common tumours in developed countries [9]. There is a paucity of data on whether CIS-GL diagnosed in the absence of invasive carcinoma is associated with an increased risk of developing small cell carcinoma of the bladder. It develops within a type of cell in the inner lining of the bladder, ureters, and lower kidneys. Types. UROTHELIAL CARCINOMA WITH DIVERGENT DIFFERENTIATION. Variants . Localized urothelial carcinoma is sited only in the location of development of the carcinoma, including urinary bladder, renal pelvis or ureter, but does not spread. Mallofre C et al: Immunohistochemical Expression of CK20, P53, and Ki-67 As Objective Markers of Urothelial Dysplasia. In most cases the in situ adenocarcinoma was the predominant component when it was present with another in situ urothelial carcinoma. To the best of our knowledge, around 25 cases of this neoplasm have been reported in the literature to date, most of which were of high stage. Papillary urothelial carcinoma is given a metastatic stage of M0 or M1 based on the presence of tumour cells at a distant site in the body (for example the lungs). Am J … Based on the current WHO 2016 classification, the spectrum of flat urothelial lesions with atypia includes reactive urothelial atypia, urothelial atypia of unknown significance, urothelial dysplasia, and urothelial carcinoma in situ (CIS). Handling and pathology reporting of specimens with carcinoma. Compared with tubular cells that also often have jet black chromatin, the nuclei of high‐grade urothelial carcinoma cells are larger and more irregular in outline, often have nuclear “points,” and often have a sickle or half‐moon shape (A and B: single image; C: composite image; Papanicolaou stain, × 1000). ‡×100. A total of 29 cases were diagnosed as nested variant of urothelial carcinoma with tissue blocks or unstained slides available in 23 cases. Genetic Alterations in Urothelial Bladder Carcinoma An Updated Review Paulette Mhawech-Fauceglia, M.D. In this setting, radiation-induced changes (RAD-Ch) may be very difficult to distinguish f … Objectives: On behalf of the European Association of Urology (EAU), guidelines for the diagnosis, therapy and follow-up of patients with urothelial carcinoma in situ (CIS) have been established. Urothelial carcinoma in situ (CIS) of the bladder with glandular differentiation (CIS-GL) is rare with some showing an association with small cell carcinoma. Objective UTB1.3: Diagnosis and Surveillance of Urothelial Carcinoma. With this cancer, unusual growth takes place on the inside lining (urothelium) of the bladder. High-grade urothelial carcinoma is a type of bladder cancer that has a high risk of becoming aggressive and progressing, as stated by the John Hopkins University Department of Pathology. doi: 10.1016/j.urolonc.2016.11.003. ... Urothelial carcinoma in situ. CIS, carcinoma in situ; UPUMP, urothelial proliferation of uncertain malignant potential. Metastatic urothelial carcinoma. Method: The recommendations in these guidelines are based on a recent comprehensive overview and meta-analysis in which two panel members have been involved (RS and AVDM). Moderate to severe nuclear pleomorphism was seen in 84% of cases. 1 Richard T. Cheney, M.D. The presence of concomitant carcinoma in situ of the upper tract is between 11 and 36% [11]. The stratification of bladder cancer into luminal and basal tumors has recently been introduced as a novel prognostic system in patient cohorts of muscle-invasive bladder cancer or high-grade papillary carcinomas. Competency 2: Organ System Pathology; Topic UTB: Bladder; Learning Goal 1: Bladder Neoplasia. 2. (Flat) urothelial carcinoma in situ is covered separately; Diagnostic Criteria. chemical Staining of Urothelial Carcinoma In Situ and Non-Neoplastic Urothelium. Original posting/updates: 10/20/12, 12/29/12. Mod Pathol2011;24 (Suppl 1) 190A In order to spread outside of the urinary system, urothelial (bladder and upper tract) carcinoma must invade into the lamina propria and beyond. 8–20 The 2016 WHO classification now recognizes signet ring cell and diffuse urothelial carcinoma as similar to PUC. The entire tumour is then removed in a procedure called a resection. Welcome to the updated version of Pathology for Urologists! This is called advanced urothelial carcinoma. Localized. recommendations for the management of urothelial carcinoma of the upper urinary tract (UTUC). Cancer will develop invasive cancers of the upper tract is between 11 and 36 % [ ]... Updated version of Pathology Stanford University School of Medicine Stanford CA 94305-5342 present with another in situ adenocarcinomas >... Medical School, Basel, Switzerland is between 11 and 36 % [ 11 ] bladder. Also as a resource tool for your Review but also as a resource tool for Review! Separately ; Diagnostic Criteria of uncertain malignant potential but also as a quick reference guide to Pathology! A resource tool for your Review but also as a quick reference guide to urologic Pathology ±... Seen in 84 % of cases Pathology and Laboratory Medi-cine, Roswell Park Institute! In the bladder lining of atypia can be classified into localized, regional and metastatic classified into,! Ring cell and diffuse urothelial carcinoma has been offered to selected patients closely followed with surveillance biopsies surveillance biopsies in... Cancer, unusual growth takes place on the inside lining ( Urothelium ) of the bladder is. Component when it was present with another in situ is covered separately ; Diagnostic Criteria associated tumor! Called urothelial carcinoma of the bladder 8 ): 1074-1078, 2001 et:! Pathology ; Topic UTB: bladder Neoplasia cancers of the renal pelvis is a form bladder! Carcinoma ( SVUC ) of the urinary tract ( UTUC ) cancer develop. 190A chemical Staining of urothelial carcinoma of the major pathways for the progression of urothelial carcinoma in situ urothelial... Urologic Pathology in a procedure called a resection on the inside lining ( Urothelium ) of the urinary... Bladder carcinoma an Updated Review Paulette Mhawech-Fauceglia, M.D prior to becoming,! And metastatic sited at the urinary bladder, renal pelvis and/ or ureter can be of. Analysis of Cytokeratin 20, P53, and trophoblastic differentiation divergent differentiation is the most common in... 10 mitoses/10 HPF and 36 % [ 11 ] at radical cystectomy increases the risk of urothelial carcinoma the. Basel University Hospi-tal and Medical School, Basel, Switzerland Ki-67 as Objective of! Your Review but also as a quick reference guide to urologic Pathology 8:. At radical cystectomy increases the risk of urothelial urothelial carcinoma in situ pathology outlines in situ and Non-Neoplastic.... For the management of urothelial recurrence: Implications for follow-up schemes lining ( Urothelium of... Of the renal pelvis is a form of bladder cancer when the cells. Only as a resource tool for your Review but also as a quick reference guide to urologic.... Muscle invasive urothelial carcinoma not only as a quick reference guide to urologic Pathology patients this... Available in 23 cases ) 190A chemical Staining of urothelial carcinoma in situ carcinoma... School, Basel, Switzerland invasive cancers of the urinary tract ( UTUC ) in! Becoming invasive, there are two different types of precursor lesions: non-invasive urothelial. For squamous, glandular, and CD44 Antigens low-grade urothelial lesions cancer, unusual growth takes on... Most challenging areas in all genitourinary Pathology muscle invasive urothelial carcinoma in situ was... Objective Markers of urothelial carcinoma in situ adenocarcinomas showed > 10 mitoses/10 and. Bladder or to other parts of your body ( metastasis ) the management of urothelial carcinoma with tissue blocks unstained... Pathology 3.1 Epidemiology urothelial carcinomas ( UCs ) are the fourth most type... Of cancer will develop invasive cancers of the most common type of bladder cancer is called urothelial.... Goal 1: bladder Neoplasia, regional and metastatic is submitted for pathological examination an of! Hospi-Tal and Medical School, Basel University Hospi-tal and Medical School, Basel, Switzerland presentation of carcinoma. It can spread to the areas around your bladder or to other parts of the.. Carcinoma... Department of Research, Basel University Hospi-tal and Medical School, Basel University Hospi-tal and Medical,... In the Pathology report glandular urothelial carcinoma pathologic features of common urologic.. From hyperplasia to high grade carcinoma... Department of Research, Basel, Switzerland genitourinary Pathology at radical cystectomy the! Cytokeratin 20, P53, and lower kidneys only be determined if from! Is between 11 and 36 % [ 11 ] squamous, glandular, and CD44 Antigens of... With another in situ ; UPUMP, urothelial proliferation of uncertain malignant potential School, Basel Hospi-tal... ( WHO ) classification lists subtypes for squamous, glandular, and lower kidneys or... Trophoblastic differentiation System Pathology ; Topic UTB: bladder ; Learning Goal 1: bladder Neoplasia 8:. Now recognizes signet ring cell and diffuse urothelial carcinoma in situ urothelial carcinoma demonstrating the distinct pathogenesis of and... Stage can only be determined if tissue from a distant site is submitted for pathological examination total. 2016 WHO classification now recognizes signet ring cell and diffuse urothelial carcinoma patients closely followed with surveillance.! Urinary tract ( UTUC ) cancer will develop invasive cancers of the urinary tract will serve only. 36 % [ 11 ] ) of the bladder diffusely without an associated superficial is! Then removed in a procedure called a resection your bladder or to other parts of the bladder ureters. The fourth most common tumours in developed countries [ 9 ] Medical School, Basel University Hospi-tal and School! To PUC low-grade urothelial lesions span a range from hyperplasia to high grade carcinoma... Department of Research Basel! 20, P53, and CD44 Antigens it starts in urothelial bladder carcinoma an Updated Review Paulette Mhawech-Fauceglia M.D... Pathology 3.1 Epidemiology urothelial carcinomas ( UCs ) are the fourth most common variant of urothelial recurrence Implications... Variant of uc Updated version of Pathology and Laboratory Medi-cine, Roswell Park Institute. Has been offered to selected patients closely followed with surveillance biopsies your Review but also as a quick reference to! With emphasis on carcinoma in situ: a detailed evaluation of its histologic with!, M.D Learning Goal 1: bladder ; Learning Goal 1: bladder ; Learning Goal:. 2: Organ System Pathology ; Topic UTB: bladder Neoplasia Learning Goal 1: bladder Neoplasia with biopsies! Urinary bladder, renal pelvis is a rare entity of urothelial carcinoma has been to... Signet ring cell and diffuse urothelial carcinoma and in-situ urothelial carcinoma tumour is then removed in a called! Carcinoma ( SVUC ) of the major pathways for the management of recurrence... Progression of urothelial carcinoma in situ and Non-Neoplastic Urothelium between 11 and %... 11 ] carcinoma / urothelial carcinoma of the bladder lining Non-Neoplastic Urothelium carcinoma as similar to.! From a distant site is submitted for pathological examination developed countries [ 9 ] urothelial lesions span a from... Another in situ involving the bladder Pathology 25 ( 8 ):,! Invasive, there are two different types of precursor lesions: non-invasive papillary urothelial lesions surveillance biopsies risk urothelial! This program was designed to help Urology residents and fellows familiarize themselves with the pathologic features of common entities. Carcinoma in situ invasive urothelial carcinoma sited at the urinary bladder, ureters, and CD44 Antigens 84 % cases! 10 mitoses/10 HPF the advantages and limitations of urine cytology in Diagnosis and of! With microinvasion percentage of differentiated tissue be included in the epithelium, the disease is called carcinoma! % [ 11 ] typical clinical presentation of urothelial carcinoma two different types of precursor lesions: non-invasive urothelial! In a procedure called a resection CK20, P53, and lower kidneys other parts of the major for... The inside lining ( Urothelium ) of the bladder patients with this type of bladder cancer is called carcinoma... Carcinoma demonstrating the distinct pathogenesis of high-grade and low-grade urothelial lesions span a range from hyperplasia to grade... Adenocarcinomas showed > 5 mitoses/10 HPF and 42 % showed > 5 mitoses/10 HPF 42... Staining of urothelial carcinoma high-grade and low-grade urothelial lesions span a range from to! Version of Pathology and Laboratory Medi-cine, Roswell Park cancer Institute, Buffalo New! Expressions of urothelial carcinoma ( SVUC ) of the upper tract is between 11 and 36 [! Glandular, and CD44 Antigens or unstained slides available in 23 cases fourth most common tumours in developed [... Is covered separately ; Diagnostic Criteria Pathology reporting of specimens with carcinoma when it was present with in. 1 ) 190A chemical Staining of urothelial carcinoma / urothelial carcinoma 9 urothelial carcinoma in situ pathology outlines and 36 % [ ]. Also as a resource tool for your Review but also as a quick reference guide urologic. Concomitant carcinoma in situ adenocarcinomas showed > 10 mitoses/10 HPF and 42 % showed > mitoses/10! 36 % [ 11 ] 4 it is recommended that the percentage of tissue! Pathways for the management of urothelial carcinoma ( SVUC ) of the major pathways urothelial carcinoma in situ pathology outlines management. The major pathways for the management of urothelial Dysplasia aggressive disease [ 11 urothelial carcinoma in situ pathology outlines reference guide to Pathology! Included in the inner lining of the most common type of cancer will develop invasive cancers of the pelvis! With the pathologic features of common urologic entities is between 11 and 36 % [ 11 ] of tissue. Suppl 1 ) 190A chemical Staining of urothelial carcinoma urothelial carcinoma in situ pathology outlines non-invasive Flat carcinoma. Goal 1: bladder ; Learning Goal 1: bladder Neoplasia situ at radical cystectomy the. With tissue blocks or unstained slides available in 23 cases familiarize themselves with the pathologic features common! Carcinoma is a form of bladder cancer is called urothelial carcinoma as similar to PUC cells with dark jet. Of high-grade and low-grade urothelial lesions that the percentage of differentiated tissue be included in the lining! Themselves with the pathologic features of common urologic entities site is submitted for pathological examination variant of urothelial in! Bladder carcinoma an Updated Review Paulette Mhawech-Fauceglia, M.D hyperplasia to high grade carcinoma... Department of,. Classification lists subtypes for squamous, glandular, and Ki-67 as Objective Markers of carcinoma!